Postdoc Scalability of Personalised Drug Manufacturing

Postdoc Scalability of Personalised Drug Manufacturing

Published Deadline Location
29 Jul 24 Aug Rotterdam

You cannot apply for this job anymore (deadline was 24 Aug 2024).

Browse the current job offers or choose an item in the top navigation above.

Erasmus School of Health Policy & Management (ESHPM) is an academic partner in the NANOSPRESSO project.

Job description

Erasmus School of Health Policy & Management (ESHPM) is an academic partner in the NANOSPRESSO project, funded by the Dutch Research Agenda and coordinated by Utrecht University. NANOSPRESSO aims to investigate, develop, and implement a technology for decentralized and small-scale production of high quality and affordable nucleic acid nanomedicines for the treatment of rare diseases. This technology enables local production of nucleic acid therapies based on the specific needs of an individual patient. This personalised approach especially improves the quality of care for patients with genetically determined (rare) diseases but particularly also for patients with selected cancers for which cellular therapies are indicated.

For NANOSPRESSO, we are looking for a Postdoc (0.8 FTE - 1.0 FTE) to work in a team of experts on the implementation and scalability of personalised drug manufacturing in contemporary health systems.

Background
In Europe, an orphan disease is defined as a condition that affects no more than 1 person in every 2,000 of the population. There are between 5,000 and 8,000 rare diseases, most of them (72%) have a genetic basis. Unfortunately, there is a lack of effective personalised treatment options for many patients with (ultra-)orphan diseases. The same holds for cancer, with an increasing number of patients receiving personally manufactured therapies like CAR-T or TIL. As cancer and many orphan diseases are genetic in nature, administering gene replacement therapy or gene editing of the defective or missing protein could be an effective cure. Both, mRNA and gene therapy technologies, belong to the advanced therapy medicinal products (ATMPs) in the medical field. Several pharmacy departments at university hospitals have now approved laboratory facilities that adhere to good manufacturing practice standards to produce and manufacture personalised therapies. And within this context, NANOSPRESSO particularly aims to develop cartridges to deliver off-the-shelf mRNA based gene replacement therapies. Although these therapies hold the promise to cure fatal diseases, the market is confronted with high development costs, uncertain regulatory pathways and concerns about scalability (i.e. capacity constraints), in particular regarding in-house compounding of personalised drugs.

Job description
We are recruiting a Postdoc to investigate the scalability of personalised drug manufacturing including gene replacement or gene editing therapies. Issues considered are the production and quality control of the Active Pharmaceutical Ingredient (API), such as mRNA, which can be in-house at a limited scale for individual patients. However, the production of APIs at scale is challenging because of quality assurance and capacity needs for batch production in the hospital and thus requires external suppliers such as specialised pharmaceutical industry. Also, for production of personalised drugs based on the genetic make-up, a highly specialised team and facilities for comprehensive -omics (genomics, proteomics, metabolomics) analysis should be available. Tertiary hospitals do provide this level of specialised care but are not necessarily the best place for offering all clinical services that require regular and frequent follow-up or management of co-morbidities associated with the primary disease. For offering high quality clinical services, therefore, a second level of complexity comes to play when deciding about the best place where care is delivered and under what institutional arrangements (centre of reference vs. community or teaching hospitals). This Postdoc position is proposed to shed light, from a health systems perspective, on the optimal integration of personalised genetic therapies in contemporary health systems. For the project to be successful, it requires a thorough understanding of the clinical background, the pharmaceutical regulatory framework for ATMPs and detailed knowledge of complex health systems and quantitative approaches to determine optimal care delivery.

Specifications

Erasmus University Rotterdam (EUR)

Requirements

We are looking for someone from or with strong affinity to the medical sciences and the business and economic aspects of implementing new genetically determined therapies. For this position, we are looking for a candidate with
  • PhD in economics, health economics, management science, industrial engineering, operations research, public health or related programme.
  • Strong quantitative research skills.
  • Excellent communication and writing skills in English.
  • A team player who wants to contribute to the interdisciplinary research agenda of ESHPM.
  • Intellectual openness and strong soft skills to effectively work in multidisciplinary teams to tackle important health problems.

As a Postdoc at ESHPM, your primary duty will be to conduct research and generate research output. Teaching and (PhD) student supervision is not expected but can be accommodated if the candidate wishes to be engaged in these activities. Funding acquisition and project management duties are expected insofar related to the NANOSPRESSO project.

Conditions of employment

We offer you an internationally oriented and varied job in an enthusiastic team, with excellent working conditions in accordance with the Collective Labour Agreement for Dutch Universities (CAO-NU).

The start date of this position is 01-OCT-2024 and you will be based at Campus Woudestein in Erasmus School of Health Policy & Management (ESHPM). This position is for 0.8 fte - 1 fte. The salary is dependent on your experience and knowledge and ranges from a minimum of € 4.332 to a maximum of € 5.929 gross per month Scale 11 on a fulltime basis (38 hours), in accordance with the CAO-NU. The contract is entered into for the duration of 2 years.

Everything else we offer you, you can find below!

Employer

Erasmus University Rotterdam

Erasmus University Rotterdam (EUR) is an internationally oriented university with a strong social orientation in its education and research, as expressed in our mission ‘Creating positive societal impact’. EUR is home to 4.100 academics and professionals and almost 33.000 students from more than 140 countries. Everything we do, we do under the credo The Erasmian Way – Making Minds Matter. We’re global citizens, connecting, entrepreneurial, open-minded, and socially involved. These Erasmian Values function as our internal compass and create EUR’s distinctive and recognizable profile. From these values, with a broad perspective and with an eye for diversity, different backgrounds and opinions, our employees work closely together to solve societal challenges from the dynamic and cosmopolitan city of Rotterdam. Thanks to the high quality and positive societal impact of our research and education, EUR can compete with the top European universities. www.eur.nl.

Faculty / Institute / Central service
The Erasmus School of Health Policy & Management (ESHPM) is a leading institute based in Rotterdam the Netherlands, specialising in healthcare policy and management across disciplines like economics, law, socio-medical sciences, organisation science, and public administration. ESHPM educates about 1,600 students and employs around 200 faculty members.

Department

see department

Department
The Postdoc position will be embedded within the Health Services Management and Organisation (HSMO) department of ESHPM.

The HSMO department is home to about 40 researchers from various backgrounds and disciplines (operations management, psychology, economics, health sciences). Focus areas include Value-Based Healthcare, Digital Transformation of Healthcare as well as Data-Driven Health Services Research.

In addition to the NANOSPRESSO consortium (with Professor Ray Schiffelers and Professor Marieke de Bruin, both Utrecht University), the Postdoc will also benefit from extensive collaboration with the Health Systems and Insurance department (Professor Marco Varkevisser) and the close proximity of Erasmus Medical Centre including the Centre for Rare Diseases (Chair Professor Edward Nieuwenhuis).

Specifications

  • Postdoc
  • Health
  • 32—40 hours per week
  • €4332—€5929 per month
  • Doctorate
  • 4496

Employer

Erasmus University Rotterdam (EUR)

Learn more about this employer

Location

Burgemeester Oudlaan 50, 3062PA, Rotterdam

View on Google Maps

Interesting for you